Induced Pluripotent Stem Cells A Powerful Neurodegenerative Disease Modeling Tool for Mechanism Study and Drug Discovery

被引:18
|
作者
Chang, Chia-Yu [1 ,2 ]
Ting, Hsiao-Chien [1 ]
Liu, Ching-Ann [1 ,2 ]
Su, Hong-Lin [3 ]
Chiou, Tzyy-Wen [4 ]
Harn, Horng-Jyh [1 ,5 ,6 ]
Lin, Shinn-Zong [1 ,7 ]
机构
[1] Buddhist Tzu Chi Med Fdn, Bioinnovat Ctr, Hualien, Taiwan
[2] Buddhist Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan
[3] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan
[4] Natl Dong Hwa Univ, Dept Life Sci, Hualien, Taiwan
[5] Buddhist Tzu Chi Gen Hosp, Dept Pathol, Hualien, Taiwan
[6] Tzu Chi Univ, Hualien, Taiwan
[7] Buddhist Tzu Chi Gen Hosp, Dept Neurosurg, Hualien, Taiwan
关键词
Neurodegenerative disease; induced pluripotent stem cells (iPSCs); disease modeling; neuronal differentiation; mechanism study; drug screening; SPINAL MUSCULAR-ATROPHY; FAMILIAL ALZHEIMERS-DISEASE; MIDBRAIN DOPAMINE NEURONS; MOTOR-NEURONS; HUMAN ES; DIRECTED DIFFERENTIATION; CEREBRAL ORGANOIDS; GENETIC CORRECTION; SELF-ORGANIZATION; IPSCS REVEALS;
D O I
10.1177/0963689718775406
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Many neurodegenerative diseases are progressive, complex diseases without clear mechanisms or effective treatments. To study the mechanisms underlying these diseases and to develop treatment strategies, a reliable in vitro modeling system is critical. Induced pluripotent stem cells (iPSCs) have the ability to self-renew and possess the differentiation potential to become any kind of adult cell; thus, they may serve as a powerful material for disease modeling. Indeed, patient cell-derived iPSCs can differentiate into specific cell lineages that display the appropriate disease phenotypes and vulnerabilities. In this review, we highlight neuronal differentiation methods and the current development of iPSC-based neurodegenerative disease modeling tools for mechanism study and drug screening, with a discussion of the challenges and future inspiration for application.
引用
收藏
页码:1588 / 1602
页数:15
相关论文
共 50 条
  • [21] Induced pluripotent stem cells: a tool for modeling Parkinson?s disease
    Bose, Anindita
    Petsko, Gregory A.
    Studer, Lorenz
    TRENDS IN NEUROSCIENCES, 2022, 45 (08) : 608 - 620
  • [22] Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells
    Hossain, Mohammed Kawser
    Dayem, Ahmed Abdal
    Han, Jihae
    Saha, Subbroto Kumar
    Yang, Gwang-Mo
    Choi, Hye Yeon
    Cho, Ssang-Goo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (02)
  • [23] Disease Modeling and Drug Discovery Using Induced Pluripotent Stem Cells From CINCA Syndrome Patients
    Tanaka, Takayuki
    Ohta, Akira
    Yanagimachi, Masakatsu
    Nishikomori, Ryuta
    Heike, Toshio
    Nakahata, Tatsutoshi
    Yamanaka, Shinya
    Saito, Megumu
    BLOOD, 2012, 120 (21)
  • [24] Pluripotent Human Stem Cells A Novel Tool in Drug Discovery
    Phillips, Blaine W.
    Crook, Jeremy M.
    BIODRUGS, 2010, 24 (02) : 99 - 108
  • [25] Modeling Neuropsychiatric and Neurodegenerative Diseases with induced Pluripotent Stem Cells
    LaMarca, Elizabeth A.
    Powell, Samuel K.
    Akbarian, Schahram
    Brennand, Kristen J.
    FRONTIERS IN PEDIATRICS, 2018, 6
  • [26] Induced pluripotent stem cells for neural drug discovery
    Farkhondeh, Atena
    Li, Rong
    Gorshkov, Kirill
    Chen, Kevin G.
    Might, Matthew
    Rodems, Steven
    Lo, Donald C.
    Zheng, Wei
    DRUG DISCOVERY TODAY, 2019, 24 (04) : 992 - 999
  • [27] Induced Pluripotent Stem Cells in Cardiovascular Drug Discovery
    Mercola, Mark
    Colas, Alexandre
    Willems, Erik
    CIRCULATION RESEARCH, 2013, 112 (03) : 534 - 548
  • [28] Pluripotent stem cells in disease modelling and drug discovery
    Yishai Avior
    Ido Sagi
    Nissim Benvenisty
    Nature Reviews Molecular Cell Biology, 2016, 17 : 170 - 182
  • [29] Pluripotent stem cells in disease modelling and drug discovery
    Avior, Yishai
    Sagi, Ido
    Benvenisty, Nissim
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2016, 17 (03) : 170 - 182
  • [30] Induced Pluripotent Stem Cells as a Disease Modeling and Drug Screening Platform
    Ebert, Antje D.
    Liang, Ping
    Wu, Joseph C.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2012, 60 (04) : 408 - 416